MEDVi is a legitimate, LegitScript-certified GLP-1 telehealth provider.
MEDVi is a licensed telehealth weight loss platform based in Newark, Delaware, that connects patients with licensed providers and dispenses compounded GLP-1 medication through pharmacy partners including Belmar Pharma Solutions and Beluga Health. It holds LegitScript certification — a third-party monitoring standard for online pharmacy and telehealth transparency — and offers both compounded and FDA-approved branded medication options.
Patient reviews of MEDVi across Trustpilot, ConsumerAffairs, and independent review sites are mixed but generally lean positive: many patients report solid weight loss results and responsive clinical care, while a recurring subset of reviews cite billing and cancellation friction. MEDVi's pricing is structured around multi-month commitment plans (3, 6, or 12 months) that offer better rates than month-to-month billing — a structure worth understanding before enrolling. Luma Health, by comparison, offers a single flat rate with no commitment plans required.
What Is MEDVi and How Does It Work?
MEDVi is a telehealth weight loss platform based in Newark, Delaware, that focuses specifically on making GLP-1 medications accessible through a cash-pay model. Patients complete an online health questionnaire, a licensed provider reviews the intake and prescribes if eligible, and medication is shipped directly to the patient's home. MEDVi partners with Belmar Pharma Solutions and Beluga Health for compounding and clinical fulfillment, and offers both compounded semaglutide/tirzepatide and FDA-approved branded GLP-1 options depending on what a patient is prescribed.
MEDVi's structural model is similar to most GLP-1 telehealth platforms: async intake, licensed provider review, and pharmacy fulfillment. Differentiating features the platform highlights include a relatively fast onboarding process, a results-based refund policy (patients who follow the program for at least five months without achieving weight loss may qualify for a refund, subject to program terms), and 24/7 access to clinician messaging.
MEDVi's advertised starting price is around $179/month, but — as with many providers in this market — the best per-month rate requires enrolling in a 3, 6, or 12-month prepaid plan rather than paying month-to-month. This is a meaningful detail for patients comparing headline pricing across providers, since a low advertised rate may not reflect what a month-to-month patient actually pays.
Legitimacy Assessment: What MEDVi Gets Right and What to Verify
✓ MEDVi Meets These Standards
- LegitScript certified — an independent transparency and compliance monitoring standard
- Uses licensed healthcare providers to authorize prescriptions
- Partners with named compounding/clinical partners (Belmar Pharma Solutions, Beluga Health)
- Offers both compounded and FDA-approved branded medication options
- Results-based refund guarantee documented in program terms
- Accepts HSA/FSA payment
- Requires a health evaluation before prescribing
⚠ Things to Verify Before Enrolling
- Best pricing requires a 3, 6, or 12-month commitment — month-to-month costs more
- A recurring subset of reviews cites billing or cancellation friction
- Pharmacy partner names are disclosed, but license numbers are not always prominent on the consumer site
- Refund guarantee terms and conditions should be read carefully before relying on them
- Reviews are mixed across platforms — read several sources, not just one
Taken together, the available evidence indicates MEDVi is a real, licensed telehealth operation delivering genuine compounded and branded GLP-1 prescriptions — not a fraudulent or counterfeit operation. The more useful question for prospective patients is not "is it a scam" but "does its pricing structure and support experience fit what I'm looking for," which is a matter of individual priorities rather than legitimacy.
What Patient Reviews Actually Say
MEDVi's reviews across independent platforms (Trustpilot, ConsumerAffairs, and third-party review roundups) present a genuinely mixed picture rather than a uniformly positive or negative one. Understanding the specific themes on both sides is more useful than any single aggregate score.
Positive Themes
Many reviews describe noticeable appetite suppression within the first two to three weeks, reported weight loss in the 10 to 25 pound range within the first two to three months, a convenient fully online process, and clinicians who exercise real clinical judgment — including at least one documented account of a provider declining to increase a patient's dose for safety reasons once their BMI had already dropped substantially.
Billing and Cancellation Friction
A recurring theme across ConsumerAffairs and other review sources is frustration with billing clarity and the cancellation process. Patients who stay enrolled and manage side effects tend to report solid results; a subset of patients who tried to cancel or dispute a charge report a more frustrating experience. This pattern — good clinical outcomes paired with occasional administrative friction — is common across the compounded GLP-1 telehealth industry and is not unique to MEDVi, though it is worth being aware of.
Commitment-Plan Pricing Confusion
Because MEDVi's best advertised pricing applies to multi-month prepaid plans, some patients report confusion about what they will actually pay if they choose month-to-month billing instead, or if they cancel before a prepaid term ends. Asking for the exact month-to-month price and the refund policy for unused prepaid months, in writing, before enrolling addresses this directly.
MEDVi vs. Luma Health: Side-by-Side Comparison
| Factor | MEDVi | Luma Health |
|---|---|---|
| Clinical model | Provider-led, cash-pay, compounded + branded options | Provider-led (Wasef Health, PC), compounded |
| Starting price | ~$179/mo (best rate needs 3–12 mo. commitment) | $197/mo flat — no commitment needed |
| Pricing structure | Tiered by plan length; month-to-month costs more | ✓ Flat — never changes with dose or term |
| Pharmacy partners named | Belmar Pharma Solutions, Beluga Health | ✓ VialsRX, TX Board #35264 (publicly verifiable) |
| Certification | LegitScript certified | Licensed clinical & pharmacy partners |
| Refund/guarantee policy | Results-based refund after 5 months (terms apply) | Month-to-month, no long-term commitment risk |
| Contract required for best price | Yes — 3/6/12-month plans | ✓ None — month-to-month always |
| Review sentiment | Mixed — positive results, some billing/cancellation friction | Provider-led, transparent flat-rate model |
| Free shipping | Reported 2–3 day delivery in some reviews | ✓ Always free — all 50 states |
How to Verify Any GLP-1 Provider's Legitimacy
Whether evaluating MEDVi, Luma Health, or any other GLP-1 telehealth platform, the following verification checklist identifies the minimum transparency standards that legitimate, responsible providers should meet.
- ☑Named compounding pharmacy with verifiable state board license. Ask the provider which compounding pharmacy prepares your medication, and verify that pharmacy's license number through the relevant state pharmacy board's public database. Luma Health uses VialsRX (Texas State Board license #35264, verifiable at pharmacy.texas.gov).
- ☑Named clinical provider or provider network. Ask who issues your prescription and what organization employs or contracts with those providers. Luma Health uses Wasef Health, PC.
- ☑Published, transparent pricing at all dose tiers and plan lengths. Ask specifically what the price is month-to-month versus with a prepaid commitment, and get that answer in writing before providing payment information.
- ☑Substantive health evaluation before prescribing. Any platform that prescribes GLP-1 medications without reviewing your health history, current medications, BMI, and contraindications is not conducting appropriate clinical evaluation.
- ☑Clear cancellation and refund process. A legitimate provider should be able to describe exactly how to cancel — the specific steps, the notice period required, and whether unused prepaid amounts are refundable.
- ☑Third-party certifications. LegitScript certification and similar independent monitoring programs are a positive signal, though they should be verified directly on the certifying organization's site rather than taken solely on a company's own claim.
No commitment plans.
One flat rate, always.
Compounded semaglutide $197/month flat. VialsRX pharmacy (TX Board #35264). No contracts. Wasef Health, PC clinical oversight.
Start With Luma Health →Frequently Asked Questions
No. Based on publicly available information, MEDVi is a licensed telehealth platform that delivers real compounded and FDA-approved GLP-1 medication through licensed providers, and it holds LegitScript certification, a third-party standard for telehealth and online pharmacy transparency. Patient reviews are mixed — some cite billing or cancellation friction — but this reflects operational experience rather than evidence of fraud.
MEDVi advertises a starting price of around $179/month, but the best rate is generally tied to enrolling in a 3, 6, or 12-month prepaid plan. Month-to-month billing without a commitment tends to cost more per month. Before enrolling, ask MEDVi directly for the exact month-to-month price at your expected maintenance dose and the refund policy if you need to cancel a prepaid plan early.
Across independent review platforms, the most recurring concerns involve billing clarity and the cancellation process — some patients report unexpected charges or difficulty getting a cancellation processed promptly. These complaints exist alongside a substantial number of positive reviews describing good clinical results and responsive provider communication. Reading multiple review sources rather than relying on a single aggregate score gives a more complete picture.
Yes. MEDVi's prescriptions are authorized by licensed healthcare providers who review each patient's health history and eligibility. As with any telehealth GLP-1 provider, patients should confirm that a licensed clinician — not an automated system alone — is making the prescribing decision, which is standard practice for legitimate providers in this space.
Both platforms provide compounded semaglutide and tirzepatide through licensed telehealth intake. The key differences: Luma Health charges a single flat rate ($197/month for semaglutide, $297/month for tirzepatide) with no commitment plan required, while MEDVi's best pricing depends on enrolling in a multi-month prepaid plan. Luma Health names its compounding pharmacy (VialsRX, TX Board #35264) with a publicly verifiable license; MEDVi discloses its pharmacy partners (Belmar Pharma Solutions, Beluga Health) by name as well. For patients who want pricing certainty without a prepaid commitment, Luma Health's model may be simpler to evaluate.
Based on publicly available patient reviews, some patients have reported friction in the cancellation process. The most reliable approach is to submit a written cancellation request through the official patient portal or support channel, document the submission with a screenshot and date, and follow up in writing if you do not receive confirmation within a few business days. If you are on a prepaid commitment plan, confirm the refund policy for unused months before assuming a partial refund is available. Verify current cancellation procedures directly with MEDVi rather than relying on third-party summaries.
Yes. The GLP-1 telehealth market in 2026 includes multiple established providers with varying pricing structures. Luma Health offers compounded semaglutide at $197/month flat and tirzepatide at $297/month flat with no commitment plans, no dose-tier increases, and a publicly verifiable pharmacy license. Henry Meds, Hims, Ro, and Found are other established options, each with their own pricing structure and program design. Comparing month-to-month pricing at your expected maintenance dose — not just headline starting prices — is the most useful way to evaluate any of these options against each other.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- LegitScript. Online Pharmacy and Telehealth Certification Standards. legitscript.com
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- Texas State Board of Pharmacy. License Verification — VialsRX #35264. pharmacy.texas.gov
- American Telemedicine Association. Telehealth Practice Guidelines. americantelemed.org
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov